Nitin Jain, MD, MD Anderson Cancer Center

home / contributors / nitin-jain-md-md-anderson-cancer-center

Articles

Lifestyle Changes After Being Diagnosed with CLL

Lifestyle Changes After Being Diagnosed with CLL

Nitin Jain, MD, MD Anderson Cancer Center;Samantha Rine;Doug Rine
October 14th 2020

Read More

Advice for Patient's and Caregivers

Advice for Patient's and Caregivers

Nitin Jain, MD, MD Anderson Cancer Center;Samantha Rine;Doug Rine
October 14th 2020

Read More

Chronic Lymphocytic Leukemia Support Network

Chronic Lymphocytic Leukemia Support Network

Nitin Jain, MD, MD Anderson Cancer Center;Samantha Rine;Doug Rine
October 14th 2020

Read More

Achieving Minimum Residual Disease Remission

Achieving Minimum Residual Disease Remission

Nitin Jain, MD, MD Anderson Cancer Center;Samantha Rine;Doug Rine
October 14th 2020

Read More

The Patient's Role in Deciding a Treatment

The Patient's Role in Deciding a Treatment

Nitin Jain, MD, MD Anderson Cancer Center;Samantha Rine;Doug Rine
October 14th 2020

Read More

CD20 Monoclonal Antibody Dose Adjustment and MRD

CD20 Monoclonal Antibody Dose Adjustment and MRD

Nitin Jain, MD, MD Anderson Cancer Center;Samantha Rine;Doug Rine
October 14th 2020

Read More

First-Hand Experience with CD20 Monoclonal Antibody Therapy

First-Hand Experience with CD20 Monoclonal Antibody Therapy

Nitin Jain, MD, MD Anderson Cancer Center;Samantha Rine;Doug Rine
October 14th 2020

Read More

CLL Treatment Decision Factors

CLL Treatment Decision Factors

Nitin Jain, MD, MD Anderson Cancer Center;Samantha Rine;Doug Rine
October 14th 2020

Read More

Chronic Lymphocytic Leukemia Diagnostic Process

Chronic Lymphocytic Leukemia Diagnostic Process

Nitin Jain, MD, MD Anderson Cancer Center;Samantha Rine;Doug Rine
October 14th 2020

Read More

The First Signs of Leukemia

The First Signs of Leukemia

Nitin Jain, MD, MD Anderson Cancer Center;Samantha Rine;Doug Rine
October 14th 2020

Read More

Latest Updated Articles

Image of man and doctor.
Published: April 12th 2025 | Updated: May 1st 2025
NeuroSAFE May Increase Erectile Function After Prostate Cancer Surgery
The FDA has approved penpulimab-kcqx with chemotherapy and as a single agent for some patients with nasopharyngeal carcinoma: © stock.adobe.com.
Published: April 24th 2025 | Updated: May 1st 2025
FDA Approves Penpulimab-kcqx For Nasopharyngeal Carcinoma
People can help EBCI reach their goal of $20,000 dollars raised for GiveBIG 2025 by giving at endbraincancer.org/donate: © stock.adobe.com.
Published: April 22nd 2025 | Updated: May 1st 2025
Support Patient Access and Education with the End Brain Cancer Initiative for GiveBIG 2025
The End Brain Cancer Initiative is currently seeking Primary Central Nervous System Lymphoma patients and care partners to participate in an online roundtable discussion: © stock.adobe.com.
Published: March 3rd 2025 | Updated: May 1st 2025
Primary Central Nervous System Lymphoma Patient and Care Partner Roundtable Hosted by the End Brain Cancer Initiative
Registration is now open for the 2025 Know All Your Treatment Options (KAYTO25) online patient disease education event/webinar: © stock.adobe.com.
Published: March 17th 2025 | Updated: May 1st 2025
Registration Open for the 2025 Know All Your Treatment Options Webinar Hosted by the End Brain Cancer Initiative
Each May, for over a decade, the End Brain Cancer Initiative (EBCI) has presented the National HOPE Award to a brain cancer patient who deeply inspires us: © stock.adobe.com.
Published: March 18th 2025 | Updated: May 1st 2025
Nominations Open for the End Brain Cancer Initiative’s 2025 National Patient Disease Education Initiative and HOPE Award